Meta, IBM, Palo Alto Networks: Why Stephanie Link Is Doubling Down On These Tariff-Proof Tech Titans

As tariffs and trade war chatter send shivers down tech’s spine, Stephanie Link of Hightower Advisors sees opportunity – especially in software and services names with recurring revenue and minimal exposure to global shocks. Latest Ratings for META Date Firm Action From To Jul 2020 Desjardins Initiates Coverage On Buy View More Analyst Ratings for…

Read More

This Johnson & Johnson Analyst Turns Bullish On Shifting Focus From Stelara Concerns To Innovative Medicine

Goldman Sachs upgraded Johnson & Johnson (JNJ) from Neutral to Buy, citing underappreciated Innovative Medicine business and upcoming product cycles. Latest Ratings for JNJ Date Firm Action From To Jan 2022 Raymond James Maintains Outperform Jan 2022 Morgan Stanley Maintains Equal-Weight Dec 2021 Goldman Sachs Initiates Coverage On Neutral View More Analyst Ratings for JNJ…

Read More